Philip W. Friederich

2.7k citations

23 papers · 2.0k indexed · h-index 19

Hematology top 0.5%
Internal Medicine top 0.5%
Cardiology and Cardiovascular Medicine top 5%
Genetics top 10%
Surgery

Co-authors: Marcel Levi Harry R. Büller Jan W. ten Cate Tymen Keller C. P. Henny Embert J. Messelink Karl‐Heinz Kurth Paolo Simioni
Topics: Blood Coagulation and Thrombosis Mechanisms (12 papers)Venous Thromboembolism Diagnosis and Management (6 papers)Hemophilia Treatment and Research (5 papers)
Cited by: Internal Medicine Hematology Critical Care and Intensive Care Medicine
Journals: The Lancet Circulation Journal of Clinical Investigation
Partner nations: Netherlands Russia Canada

In The Last Decade

Philip W. Friederich

23 papers receiving 1.9k citations

Peers

Countries citing papers authored by Philip W. Friederich

Since Specialization

Citations

This map shows the geographic impact of Philip W. Friederich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip W. Friederich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip W. Friederich more than expected).

Fields of papers citing papers by Philip W. Friederich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip W. Friederich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip W. Friederich. The network helps show where Philip W. Friederich may publish in the future.

Co-authorship network of co-authors of Philip W. Friederich

This figure shows the co-authorship network connecting the top 25 collaborators of Philip W. Friederich. A scholar is included among the top collaborators of Philip W. Friederich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip W. Friederich. Philip W. Friederich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis 2023 ·Liver International ·(unknown),(unknown),Maarten E. Tushuizen,Ynto S. de Boer,(unknown),Robert A. de Man,Johannes T. Brouwer,Johan P. Kuyvenhoven,Michael Klemt‐Kropp,Tom J.G. Gevers,Eric T.T.L. Tjwa,Edith M.M. Kuiper,M.A.M.T. Verhagen,Philip W. Friederich,Bart van Hoek	5
2	REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro‐elimination in the Utrecht province 2018 ·Liver International ·(unknown),Joop E. Arends,Karel J. van Erpecum,Steven Thijsen,Bart J. M. Vlaminckx,A.J.L. Weersink,A. M. J. Wensing,(unknown),(unknown),P.H.G.M. Stadhouders,Philip W. Friederich,M.A.M.T. Verhagen,Greet J. Boland,Andy I. M. Hoepelman	31
3	Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis 2006 ·Journal of Clinical Pathology ·R. E. Kirsch,Michelle Pentecost,Pauline de la Μ. Hall,D. Epstein,Gillian Watermeyer,Philip W. Friederich	94
4	A Randomized Controlled Trial of Patient Controlled Analgesia Versus Continuous Infusion of Morphine during Vaso-Occlusive Crisis in Sickle Cell Disease. 2005 ·Blood ·Eduard J. van Beers,Pythia T. Nieuwkerk,Charlotte F.J. Van Tuijn,Philip W. Friederich,Jan Vranken,Bart J. Biemond	1
5	Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial 2003 ·The Lancet ·Philip W. Friederich,C. P. Henny,Embert J. Messelink,(unknown),Tymen Keller,Karl‐Heinz Kurth,Harry R. Büller,Marcel Levi	304
6	Activation of Coagulation by Administration of Recombinant Factor VIIa Elicits Interleukin 6 (IL-6) and IL-8 Release in Healthy Human Subjects 2003 ·Clinical and Vaccine Immunology ·Evert de Jonge,Philip W. Friederich,George P. Vlasuk,William E. Rote,(unknown),Marcel Levi,Tom van der Poll	80
7	Successful treatment with recombinant factor VIIa of therapy‐resistant severe bleeding in a patient with acquired von Willebrand disease 2001 ·American Journal of Hematology ·Philip W. Friederich,Peter C. Wever,Ernest Briët,(unknown),Marcel Levi	54
8	Ability of Recombinant Factor VIIa to Generate Thrombin During Inhibition of Tissue Factor in Human Subjects 2001 ·Circulation ·Philip W. Friederich,Marcel Levi,Kenneth A. Bauer,George P. Vlasuk,William E. Rote,(unknown),(unknown),(unknown),Samad Barzegar,Harry R. Büller	64
9	The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study 2000 ·Blood Coagulation & Fibrinolysis ·Philip W. Friederich,(unknown),(unknown),(unknown),Ch. P. Henny,H. R. Büller,Marilyn E. Levi	44
10	Successful Attenuation of Venous Thrombus Growth in Rabbits after the Administration of a Novel Oral Thrombin Inhibitor 2000 ·Thrombosis and Haemostasis ·Tymen Keller,(unknown),Ron Peters,(unknown),Harry Büller,Marcel M. Levi,Philip W. Friederich	3
11	Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits 1999 ·Nature Medicine ·Marcel M. Levi,Philip W. Friederich,Sarah Middleton,Philip G. de Groot,Ya Wu,R. Harris,Bart J. Biemond,Harry F.G. Heijnen,Jack Levin,Jan W. ten Cate	98
12	The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. 1999 ·Blood ·(unknown),Paolo Simioni,Daniela Tormene,Marco Moia,Philip W. Friederich,Menno V. Huisman,Paolo Prandoni,A. Bura-Rivière,(unknown),Philip Wells,Pier Mannuccio Mannucci,Antonio Girolami,Harry R. Büller,Martin H. Prins	123
13	Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia 1999 ·Thrombosis and Haemostasis ·Paolo Simioni,Bernd‐Jan Sanson,Daniela Tormene,Philip W. Friederich,Bruno Girolami,Sabrina Gavasso,Menno V. Huisman,Harry Büller,Jan W. ten Cate,Antonio Girolami,(unknown),Paolo Prandoni	252
14	Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. 1998 ·Journal of Clinical Investigation ·Monique C. Minnema,Philip W. Friederich,Marcel Levi,Peter A. von dem Borne,Laurent O. Mosnier,Joost C.M. Meijers,Bart J. Biemond,C. Erik Hack,Bonno N. Bouma,Hugo Ten Cate	159
15	Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer 1998 ·Annals of Oncology ·M. Gershanovich,H.A. Chaudri,(unknown),H. Lurie,Antonino Bonaventura,M Jeffrey,Franco Buzzi,I. Bodrogi,H Ludwig,Peter Reichardt,N. J. O’Higgins,Gilles Romieu,Philip W. Friederich,M. Lassus	206
16	Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo 1997 ·Circulation ·Bart J. Biemond,Philip W. Friederich,Marlys L. Koschinsky,Marcel Levi,Waheed Sangrar,(unknown),Harry R. Büller,Jan W. ten Cate	40
17	[Gluten as food additive in The Netherlands: cheese forbidden for celiac patients?]. 1997 ·PubMed ·Philip W. Friederich,(unknown),(unknown),(unknown),(unknown)	1
18	Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits. 1997 ·PubMed ·Philip W. Friederich,Marcel Levi,(unknown),Peter Charlton,Douglas M. Templeton,Anton Jan van Zonneveld,Paul Bevan,Hans Pannekoek,J W ten Cate	78
19	Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis 1996 ·Annals of Internal Medicine ·Philip W. Friederich,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	159
20	Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study. 1990 ·Journal of Clinical Oncology ·K. Höffken,W. Jonat,K. Possinger,(unknown),Tina Kunz,(unknown),R. Becher,R. Callies,Philip W. Friederich,(unknown)	69

About Philip W. Friederich

Philip W. Friederich is a scholar working on Internal Medicine, Hematology and Biochemistry, having authored 23 papers that have together received 2.0k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Hemophilia Treatment and Research (5 papers). The work is most often cited by research in Internal Medicine (547 citations), Hematology (1.2k citations) and Critical Care and Intensive Care Medicine (186 citations). Philip W. Friederich has collaborated with scholars based in Netherlands, Russia and Canada. Frequent co-authors include Marcel Levi, Harry R. Büller, Jan W. ten Cate, Tymen Keller, C. P. Henny, Embert J. Messelink, Karl‐Heinz Kurth, Paolo Simioni, Daniela Tormene and Paolo Prandoni. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact